Hiroshi Jokaji

919 total citations
36 papers, 703 citations indexed

About

Hiroshi Jokaji is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Hiroshi Jokaji has authored 36 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 15 papers in Pulmonary and Respiratory Medicine and 9 papers in Internal Medicine. Recurrent topics in Hiroshi Jokaji's work include Blood Coagulation and Thrombosis Mechanisms (23 papers), Blood properties and coagulation (14 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Hiroshi Jokaji is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (23 papers), Blood properties and coagulation (14 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Hiroshi Jokaji collaborates with scholars based in Japan and United States. Hiroshi Jokaji's co-authors include Hidesaku Asakura, Eriko Morishita, Ichiro Kumabashiri, Chika Uotani, Masanori Saito, Tamotsu Matsuda, Masahide Yamazaki, Keiji Aoshima, Hiroshi Yamazaki and Mikako Saito and has published in prestigious journals such as Blood, Diabetes and Annals of the New York Academy of Sciences.

In The Last Decade

Hiroshi Jokaji

36 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Jokaji Japan 17 334 212 173 150 123 36 703
Chika Uotani Japan 18 363 1.1× 201 0.9× 188 1.1× 202 1.3× 117 1.0× 45 749
Masahide Yamazaki Japan 17 348 1.0× 120 0.6× 147 0.8× 176 1.2× 129 1.0× 46 761
Andrea Finch United States 8 285 0.9× 256 1.2× 117 0.7× 224 1.5× 132 1.1× 9 683
Kouzou Minamikawa Japan 14 339 1.0× 138 0.7× 143 0.8× 113 0.8× 91 0.7× 24 606
M. Blombäck Sweden 18 552 1.7× 185 0.9× 168 1.0× 176 1.2× 146 1.2× 46 1.0k
Thompson Cb United States 8 250 0.7× 178 0.8× 150 0.9× 128 0.9× 72 0.6× 9 633
S Barzegar United States 11 507 1.5× 222 1.0× 187 1.1× 118 0.8× 85 0.7× 15 781
Jim Thom Australia 17 473 1.4× 401 1.9× 167 1.0× 111 0.7× 148 1.2× 29 1.0k
Tamara Brunelli Italy 12 197 0.6× 133 0.6× 108 0.6× 124 0.8× 128 1.0× 26 775
Shogo Takano Japan 6 387 1.2× 163 0.8× 268 1.5× 113 0.8× 134 1.1× 13 703

Countries citing papers authored by Hiroshi Jokaji

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Jokaji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Jokaji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Jokaji more than expected).

Fields of papers citing papers by Hiroshi Jokaji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Jokaji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Jokaji. The network helps show where Hiroshi Jokaji may publish in the future.

Co-authorship network of co-authors of Hiroshi Jokaji

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Jokaji. A scholar is included among the top collaborators of Hiroshi Jokaji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Jokaji. Hiroshi Jokaji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Norio, Tomohito Hamazaki, Hiroshi Jokaji, Shinji Minami, & Masashi Kobayashi. (1998). Effect of HMG-CoA reductase inhibitors on plasma polyunsaturated fatty acid concentrations in patients with hyperlipidemia. International Journal of Clinical & Laboratory Research. 28(3). 192–195. 30 indexed citations
2.
Yamazaki, Masahide, Hidesaku Asakura, Masanori Saito, et al.. (1998). Prothrombin Fragment 1+2 Measures Treatment Effect in Patients with Antiphospholipid Syndrome. Thrombosis Research. 91(3). 121–128. 4 indexed citations
3.
Morishita, Eriko, Hidesaku Asakura, Hiroshi Jokaji, et al.. (1996). Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus. Atherosclerosis. 120(1-2). 7–14. 49 indexed citations
4.
Morishita, Eriko, Shinji Nakao, Hiroshi Asakura, et al.. (1996). Hypercoagulability and high lipoprotein(a) levels in patients with aplastic anemia receiving cyclosporine. Blood Coagulation & Fibrinolysis. 7(6). 609–614. 7 indexed citations
5.
Yamazaki, Masahide, Hidesaku Asakura, Keiji Aoshima, et al.. (1996). Protective Effects of DX-9065a, an Orally Active, Novel Synthesized and Selective Inhibitor of Factor Xa, Against Thromboplastin-Induced Experimental Disseminated Intravascular Coagulation in Rats. Seminars in Thrombosis and Hemostasis. 22(3). 255–259. 20 indexed citations
6.
Ishiura, Yoshihisa, et al.. (1996). Intrapleural corticosteroid injection therapy for post-traumatic eosinophilic pleural effusion. Respiratory Medicine. 90(8). 501–503. 10 indexed citations
7.
Saito, Masanori, Hidesaku Asakura, Hiroshi Jokaji, et al.. (1995). Mechanism of Activation of Coagulation Induced by Tissue-Type Plasminogen activator : Studies by Using Coagulation Factor Deficient Plasma. 6(6). 453–457. 2 indexed citations
8.
Saito, Masanori, Hidesaku Asakura, Hiroshi Jokaji, et al.. (1995). Mechanism of Activation of Coagulation Induced by Tissue-Type Plasminogen activator. Japanese Journal of Thrombosis and Hemostasis. 6(6). 453–457. 2 indexed citations
9.
Yamazaki, Hiroshi, Hiroshi Asakura, Mikako Saito, et al.. (1995). Relationship between elevation in the plasma concentration of elastase-??1 proteinase inhibitor complex (E-??1PI) and haemostatic parameters during haemodialysis. Blood Coagulation & Fibrinolysis. 6(1). 5–10. 3 indexed citations
10.
Asakura, Hiroshi, Toshimi Yoshida, Hiroshi Jokaji, et al.. (1995). Levels of activated factor VII in patients with disseminated intravascular coagulation [letter]. Blood. 85(12). 3770–3771. 1 indexed citations
11.
Asakura, Hidesaku, Hiroshi Jokaji, Mikako Saito, et al.. (1994). Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Blood Coagulation & Fibrinolysis. 5(5). 829–832. 45 indexed citations
12.
Asakura, Hidesaku, Yoshimune Shiratori, Hiroshi Jokaji, et al.. (1993). Changes in Plasma Levels of Prothrombin Fragment F1+2 in Cases of Disseminated Intravascular Coagulation. Acta Haematologica. 89(1). 22–25. 18 indexed citations
13.
Yamazaki, Hiroshi, Hidesaku Asakura, Hiroshi Jokaji, et al.. (1993). Successful treatment of a patient with idiopathic factor VIII inhibitor with double filtration plasmapheresis and steroid administration. Blood Coagulation & Fibrinolysis. 4(3). 491–496. 8 indexed citations
14.
Morishita, Eriko, Masanori Saito, Hidesaku Asakura, et al.. (1992). Increased levels of plasma thrombomodulin in chronic myelogenous leukemia. American Journal of Hematology. 39(3). 183–187. 23 indexed citations
15.
16.
Asakura, Hiroshi, Hiroshi Jokaji, Chika Uotani, et al.. (1990). [Leukemia and pre-DIC--coagulation and fibrinolytic parameters in severe infection at the nadir of leukocyte after chemotherapy].. PubMed. Suppl 86. 158–63. 1 indexed citations
17.
Saito, Masanori, et al.. (1990). Role of D Dimer in Patients with Elevated Fibrinogen Degradation Products in Serum: Further Study in Chronic Myelogenous Leukemia. Acta Haematologica. 84(3). 149–155. 3 indexed citations
18.
Saito, Masanori, Hidesaku Asakura, Chika Uotani, et al.. (1989). Quantitative estimation of elastase-α1-proteinase inhibitor (E-α1PI) complex in leukemia: Marked elevation in cases of acute promyelocytic leukemia. Thrombosis Research. 53(2). 163–171. 14 indexed citations
19.
Saito, Masanori, Hidesaku Asakura, Hiroshi Jokaji, et al.. (1989). Changes in hemostatic and fibrinolytic proteins in patients receiving L‐asparaginase therapy. American Journal of Hematology. 32(1). 20–23. 27 indexed citations
20.
Saito, Masanori, Ichiro Kumabashiri, Hiroshi Jokaji, et al.. (1988). The levels of protein C and protein S in plasma in patients with type II diabetes mellitus. Thrombosis Research. 52(5). 479–486. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chika Uotani Breakdown of academic impact, for papers by Masahide Yamazaki Breakdown of academic impact, for papers by Andrea Finch Breakdown of academic impact, for papers by Kouzou Minamikawa Breakdown of academic impact, for papers by M. Blombäck Breakdown of academic impact, for papers by Thompson Cb Breakdown of academic impact, for papers by S Barzegar Breakdown of academic impact, for papers by Jim Thom Breakdown of academic impact, for papers by Tamara Brunelli Breakdown of academic impact, for papers by Shogo Takano
Rankless by CCL
2026